Published 11:31 IST, May 5th 2024
Cipla and Glenmark issue recalls in the US drug market
The recall, classified as Class II by the US Food and Drug Administration, following complaints regarding the fill volume and liquid observed in the packaging.
Cipla and Glenmark issue recalls in the US drug market
| Image:
Pexels
- Listen to this article
- 2 min read
Advertisement
11:31 IST, May 5th 2024